TAG:
digital pathology
Examining Roche’s Deal to Acquire PathAI
CEO SUMMARY: At first glance, Roche’s announcement that it had bought digital pathology and AI firm PathAI could be seen as a narrowing of options for clinical laboratories and pathology practices. However, insider Lisa-Jean Clifford says labs have long had access to dig…
Three Signals to Take from Executive War College
We’ve arrived back from New Orleans and the 3…
Positioning the Lab as a Strategic Powerhouse
CEO SUMMARY: The 31st Annual Executive War College in New Orleans showcased speakers who have re-imagined the diagnostic laboratory’s role from back-office utility to a primary driver of system-wide strategy and clinical excellence. A consistent theme came up during doze…
Digital Pathology’s Next Wave May Be in Precision Medicine
We’ve noted before that the adoption of digital pathology has not been as swift or strong as originally predicted. Many factors contribute to that concern. This topic came up in a recent interview The Dark Report conducted with Imoge…
Tracking the Chain of Custody in Histopathology Labs
Despite increasing adoption of digital pathology systems, many histopathology laboratories remain mired in manual workflows in the critical pre-analytical phase, as specimens are collected and processed into slides. Such workflows are not only …
Six Themes Define 2026 Executive War College
CEO SUMMARY: The 31st Annual Executive War College is just eight weeks away. From financial performance to digital pathology and AI, this year’s jam-packed conference will deliver practical solutions for today’s busy clinical laboratory executives. Despite stepping dow…
Director Blissfully Uninvolved with Finances of DP Rollout
One of the biggest aspects of a clinical laboratory switching from traditional glass slides to digital pathology is the potential cost of such a project. It’s difficult to provide a reliable range of how expensive digital pathology (DP) imple…
Crucial Themes Shape 2026 Executive War College
With 2026 now upon us, our attention here at …
Top Stories in 2025 Played Out in Courts, Capitol Hill
CEO SUMMARY: The biggest story of the year for clinical laboratories came in a huge court victory, as a federal judge vacated the FDA’s final rule on laboratory developed tests. Labs breathed a sigh of relief after the court decision, as the FDA rule had promised to incr…
One Lab’s Solution to Its Histotechnologist Shortage
Histology workforce shortages remain one of the major challenges within the clinical laboratory industry, and, unfortunately, as the demand for histotechnologists increases, the number of qualified personnel has been decreasing. A report releas…
CURRENT ISSUE
Volume XXXIII, No. 7 – May 26, 2026
Momentum is building on Capitol Hill to pass the RESULTS Act, which would stave off drastic 15% reimbursement cuts under PAMA. Advocates seek lobbying help from clinical labs and anatomic pathology practices. Also, The Dark Report examines Roche’s deal to acquire PathAI.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.